APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy - Test2 - elhamkhani - TriplyDB

APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy

APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy

http://www.wikidata.org/entity/Q24631837

about

The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease Systematic reviews of animal models: methodology versus epistemology.FSGS: Diagnosis and Diagnostic Work-Up Ethnic Differences in Childhood Nephrotic Syndrome Secondary Focal Segmental Glomerulosclerosis: From Podocyte Injury to Glomerulosclerosis APOL1 Kidney Disease Risk Variants: An Evolving Landscape Opportunities and Challenges of Genotyping Patients With Nephrotic Syndrome in the Genomic Era Insights into the genetic architecture of diabetic nephropathy Kidney disease: new technologies translate mechanisms to cure Hypertension and chronic kidney disease: controversies in pathogenesis and treatment Podocyte pathology and nephropathy - sphingolipids in glomerular diseases Clinical perspectives on lupus genetics: advances and opportunities HIV and chronic kidney disease Addressing the global burden of chronic kidney disease through clinical and translational research APOL1 and nephropathy progression in populations of African ancestry APOL1 kidney risk alleles: population genetics and disease associations Update on current management of chronic kidney disease in patients with HIV infection Drug-induced glomerular disease: direct cellular injury.The African diaspora: history, adaptation and health APOL1 toxin, innate immunity, and kidney injury Population ancestry and genetic risk for diabetes and kidney, cardiovascular, and bone disease: modifiable environmental factors may produce the cures In vivo Modeling Implicates APOL1 in Nephropathy: Evidence for Dominant Negative Effects and Epistasis under Anemic Stress A review of the Institute of Medicine's analysis of using chimpanzees in biomedical research Animal models and conserved processes What Do We Know about Opioids and the Kidney?Insights into kidney diseases from genome-wide association studies.Social Determinants of Racial Disparities in CKD.Combined Effects of GSTM1 Null Allele and APOL1 Renal Risk Alleles in CKD Progression in the African American Study of Kidney Disease and Hypertension Trial Association Analysis of the Cubilin (CUBN) and Megalin (LRP2) Genes with ESRD in African Americans.Lack of Association of the APOL1 G3 Haplotype in African Americans with ESRD Getting to 90-90-90 in paediatric HIV: What is needed?Evolution of the primate trypanolytic factor APOL1 Collapsing glomerulopathy, the Saudi Arabian scenario. A study of 31 cases and a review of literature Personalized Medicine: New Perspectives for the Diagnosis and the Treatment of Renal Diseases APOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis.Explaining the racial difference in AKI incidence APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability.Coding variants in nephrin (NPHS1) and susceptibility to nephropathy in African Americans.Research capacity. Enabling the genomic revolution in Africa.

P2860

Q24594836-8E386A24-2728-45AA-86F1-F999D5AFE594 Q24599916-F5C9E840-04EF-4372-AEA1-A8199A8F176C Q24629614-E77AF88F-E9B6-41F7-B794-3C98C61D8441 Q26744558-7EC9B6E4-5451-4FD7-92E4-C9F7E3C12EE9 Q26752347-2C835010-61DD-49F9-9686-3935E200D258 Q26752830-1DDAB9DA-87A6-43F5-988E-B18367A86C5E Q26799191-B4B74B15-D31A-4979-A66C-B7B6E5291F56 Q26799197-8556C1CB-79DE-4A50-9F2B-238A1DA8C309 Q26823352-B88CAAE4-76DC-4B29-829C-B2D324F558EB Q26825227-0E075186-96BB-4809-A3C2-2CC846B2BD66 Q26851271-B52B662D-65B5-42E2-8C9B-BFED8FB2144C Q26852463-E6894D1F-9D74-4E96-BE27-0EF257D38FC5 Q27001690-CCF1F934-7BE4-4DC7-9D23-B3DCDBEA5267 Q27010688-1880C82B-5B76-4414-A445-B799E2D19EA3 Q27014158-48067FBE-A442-4776-BA56-4329F756D20A Q27022275-AB173F6B-9E0D-4009-AF69-00C221095453 Q27024261-B0DF435A-C71E-4CF9-95D8-D56E9E9806BC Q27691460-751BCF4D-7517-4166-9566-5A0C0CDAC4A3 Q27692666-79D2509A-3890-4E1E-80E9-E7FEDD670820 Q28075805-88D016FB-782D-4943-A905-8622D94ACC83 Q28085667-5C20130C-6DE8-4145-AA2B-937925ACE106 Q28391758-3E82E083-E6DA-488C-808C-4E271591ACB4 Q28546164-C4C5E72B-03FC-40D1-B8CB-32B5EB02C700 Q28659265-51829FBB-3680-47EF-9E7A-8DF21D783896 Q28710144-BF0B4E70-45B0-44AB-A9DA-73AEBC476552 Q30238812-711304CD-3208-4FCD-BD4B-6D63537A34AE Q30248678-6723C7D5-84EA-47E3-A8B7-77BF0C24ECAC Q30250319-6C974CBD-7949-4573-9512-9019B8E846F1 Q30277219-68CBE32E-1944-4765-BB98-F3D543325474 Q30352406-DB0BC994-C3B8-4DDD-8863-00EB582719BB Q30359344-EE3CDF55-65E2-4B67-BAF2-8F16EC0B5001 Q30385352-A15BA06C-412C-4844-A746-9E8F301315AD Q33665446-44BDEF76-FC8B-40A8-B15E-B0363B5AC622 Q33735329-259831D1-9146-49AB-9F70-849426D15BD9 Q33838866-FE3E6ED1-31BF-41A2-9B69-D60877C8BDF9 Q33866444-8F972768-2EC0-4068-BD30-1EF4A9C995E4 Q33974656-083F5FBB-2C23-40F4-8F86-4EBA2565C6A4 Q34001289-7995DB73-4F3F-492C-8A86-BAA6148F88B1 Q34008876-7ABC794D-61BB-4AB5-905D-45A27EC4AB24 Q34068017-144D16AB-8450-40EF-9846-CC89F08DE681

P2860

APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy

http://www.wikidata.org/entity/Q24631837

description

2011 nî lūn-bûn

@nan

2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

APOL1 genetic variants in foca ...... and HIV-associated nephropathy

@ast

APOL1 genetic variants in foca ...... and HIV-associated nephropathy

@en

APOL1 genetic variants in foca ...... and HIV-associated nephropathy

@nl

type

label

APOL1 genetic variants in foca ...... and HIV-associated nephropathy

@ast

APOL1 genetic variants in foca ...... and HIV-associated nephropathy

@en

APOL1 genetic variants in foca ...... and HIV-associated nephropathy

@nl

prefLabel

APOL1 genetic variants in foca ...... and HIV-associated nephropathy

@ast

APOL1 genetic variants in foca ...... and HIV-associated nephropathy

@en

APOL1 genetic variants in foca ...... and HIV-associated nephropathy

@nl

P1433

Q24631837-F0269E33-DA6C-4E61-A3B5-92E3BEA47C49

P1476

Q24631837-AAC87CA0-83C6-4CCD-8E31-F543DC04D12C

P2093

Q24631837-104ECF2C-8A94-4B35-9AEA-3141A3F07640

Q24631837-17B8F211-F82F-4C8A-9DA5-2388C45635A6

Q24631837-1CC800E6-C3FE-4007-B3E2-5D314713D7EB

Q24631837-1F1CD9DA-DACB-4A9D-8830-890E382FE957

Q24631837-27A05F69-36CD-4962-91B9-C76F3FA4A31C

Q24631837-411C3AFE-4471-448C-AFD2-CE96988E6A55

Q24631837-4A2BD267-94DC-491B-934C-8A1B47901D90

Q24631837-4B6B92D7-E9BE-4D58-AEEF-146438118CDD

Q24631837-61EBA061-0C94-4B4C-9945-5C62F17F3CD2

Q24631837-70D0AFB4-8FA1-4B34-B5E6-C6B58C3099EE

P2860

Q24631837-1B44FF35-9F5A-4BAA-BAE0-425A3BE8F4F3

Q24631837-1E647834-4A63-43BC-98BD-615D970D08B7

Q24631837-235DC6E4-50D3-415F-914F-B5E092D03FA6

Q24631837-2D692ADC-0D20-41E6-8688-B1241B90FAC9

Q24631837-2D953D4C-1B45-4E83-8095-DCE391DA98D5

Q24631837-2FD0CA90-E676-4A38-8D0A-50E0BE18D7F7

Q24631837-39DAC793-ED2E-4858-BF1C-9D3B31E4B5EF

Q24631837-45815D78-F3C3-43BD-9509-2E2C0AAD5109

Q24631837-4B0130B9-8035-42BF-8F59-E9E4DC4B9913

Q24631837-4C22DF99-0A17-4E3B-852B-3B125C601601

P304

Q24631837-8D2DF630-BA2B-4A0B-B2CB-1258869CA112

P31

Q24631837-218526E6-3522-4D68-BE57-485BE578F245

P3181

Q24631837-07EA80E8-03FB-4E6D-AC42-B376C20D89BF

P356

Q24631837-4048D66B-E689-4B95-8CD6-3741D87F2701

P407

Q24631837-9AFB4290-6833-467C-9F4F-8AFBA34B5C37

P433

Q24631837-2F4028C4-99B6-44AE-89F8-53BAFC0325A4

P478

Q24631837-7A81AFA1-D814-4BDB-ACB9-0D8819A0DADF

P50

Q24631837-0FBC631D-F402-4224-99AE-923898239832

Q24631837-1EB27658-52E8-4EAD-99F2-C9BE0DF4D929

Q24631837-22E1BFB0-21DF-4BDF-B614-6C3378998FFB

Q24631837-2D926709-DED4-4FD7-A008-22616B673E29

Q24631837-3BBB1A7D-0714-489F-9487-BEA6B3B7212E

Q24631837-661EA6FE-BD6C-4FC6-8AC3-5416CACA9531

Q24631837-C13EB686-67F2-4048-B9DF-37C081730571

P577

Q24631837-B0B4A637-7FB1-4097-BBEC-1B3875C87E1A

P5875

Q24631837-9BFBCB1B-E626-4578-86CE-D73130B81FCC

P698

Q24631837-471E51C9-CE44-4224-848C-500EAE242F65

P932

Q24631837-DA65DC9F-F263-4B34-909C-E6FF1F68B1B9

P3181

P356

P1433

Journal of the American Society of Nephrology

P1476

APOL1 genetic variants in foca ...... and HIV-associated nephropathy

@en

P2093

Cheryl A Winkler

http://www.w3.org/2001/XMLSchema#string

David Friedman

http://www.w3.org/2001/XMLSchema#string

Donna M Michel

http://www.w3.org/2001/XMLSchema#string

Eric E Simon

http://www.w3.org/2001/XMLSchema#string

George W Nelson

http://www.w3.org/2001/XMLSchema#string

Giulio Genovese

http://www.w3.org/2001/XMLSchema#string

Jeffrey R Schelling

http://www.w3.org/2001/XMLSchema#string

Jeffrey S Berns

http://www.w3.org/2001/XMLSchema#string

Karmini Sampath

http://www.w3.org/2001/XMLSchema#string

Martin Pollak

http://www.w3.org/2001/XMLSchema#string

P2860

A map of recent positive selection in the human genome

Potential etiologic and functional implications of genome-wide association loci for human diseases and traits

Apolipoprotein L-I is the trypanosome lytic factor of human serum

African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans

Association of trypanolytic ApoL1 variants with kidney disease in African Americans

A map of human genome variation from population-scale sequencing

Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

A second generation human haplotype map of over 3.1 million SNPs

MYH9 is associated with nondiabetic end-stage renal disease in African Americans

P304

2129-37

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

885833

http://www.w3.org/2001/XMLSchema#string

P356

10.1681/ASN.2011040388

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

Jeffrey B. Kopp

Howard Trachtman

Randall Johnson

P577

2011-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51715375

http://www.w3.org/2001/XMLSchema#string

P698

21997394

http://www.w3.org/2001/XMLSchema#string

P932

3231787

http://www.w3.org/2001/XMLSchema#string